NCBP2 and cancer: Multiple algorithms (ESTIMATE score, Evaluating the Proportion of Immune and Cancer cells (EPIC), Cell-type Identification By Estimating Relative Subsets Of RNA Transcripts (CIBERSORT), Tumor IMmune Estimation Resource (TIMER), quantitative analysis of immune cell infiltration using RNA sequencing (QUANTISEQ), Microenvironment Cell Populations-counter (MPCOUNTER)) were employed to dissect the immune infiltrates composition of tumor microenvironment, which indicated that NCBP2 was correlated with various immune infiltrates and the expression of multiple immunomodulatory genes.